General discussion, page-9788

First 9788 Last

Share
Profile

Follow
sulmar

398 Posts.

88

24/11/21

20:09

Post #: 57828503
Share

Originally posted by 1ncog: ↑

Hi @tradingformils,

I don't think I was blindly looking at anything - I believe my queries and analysis were very specific, and I think it is fair to say that I take the time to look at things deeper than most.

You stated:
"If you read the 3rd Form F-1/A submission in detail, OSA, TBI, and IHL-675A are ALL heading straight to phase 2 FDA trials. Indeed they all seem to be skipping phase 1 FDA trials, considering the current work done at the pre-clinical and clinical level in Australia. Furthermore, there's significant known safety studies behind CBD to aid our FDA submission."

I understand this, however, I also understand that this is the intent, meaning it is yet to materialise. Hence, the reason why the pipeline progress chart on the Form F-1/A No.3, is the way it is. Do you agree with this?

You stated:
"By the looks of it, the NASDAQ listing could be any day now."

Respectfully, I ask, how do you qualify this opinion? To be honest, posters have been stating similar things for the past 2-3 months. Don't get me wrong, the sooner the better in my opinion, but I persoanlly am happy to wait and respect the process.

You stated:
"After we list (reading the 3rd Form F-1/A submission), it seems we have the following news that will drop to drive the share price and keep punters interested/speculating for months:
1. OSA results (due Q4 2021)"

That is factually incorrect. The results are due, Q1 2022, as per the screen shot below. Yes, the interim results were due in Q4 2021, however, the Company moved the timeline in an announcement dated 28/10/21, ASX website.

Thanks for your response, I really appreciate it, cheers.

This post is my humble personal opinion only, is not fact or advice - please do your own research.

Expand

I feel you take it really seriously when people say 'listing could be any day'. It's obvious people are estimating going by similar companies and how long it took them but end of the day, it's a guess because no one knows for certain.

To call out someone and question them on that comment feels a little odd.

IHL Price at posting: 54.0¢ Sentiment: Hold Disclosure: Held
13 Upvote

0 Great analysis

Reply

Top Stories

TIG

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

A3D

Defence MOU for propulsion systems pushes Aurora Lab shares higher

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

IMA

Issues emerging as Australian companies tackle critical minerals challenge

NWH

NRW Holdings inks $109M deal with BHP for works at Jimblebar

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

CXU

Cauldron Energy reports "excellent" uranium assays in latest drill run

SHN

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

RAG

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

There are more pages in this discussion • 10,655 more messages in this thread...

First 9788 Last

Add IHL (ASX) to my watchlist

General discussion, page-9788

Top Stories

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

Defence MOU for propulsion systems pushes Aurora Lab shares higher

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Issues emerging as Australian companies tackle critical minerals challenge

NRW Holdings inks $109M deal with BHP for works at Jimblebar

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

Cauldron Energy reports "excellent" uranium assays in latest drill run

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Featured News